Commentary to “Mogamulizumab‐induced photosensitivity in patients with mycosis fungoides and other T‐cell neoplasms” by Y. Masuda et al.

Linked article: This is a commentary on Y. Masuda et al., pp. 1456–1460 in the previous issue. To view this article visit https://doi.org/10.1111/jdv.14797

Detalles Bibliográficos
Autor principal: Hönigsmann, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221007/
https://www.ncbi.nlm.nih.gov/pubmed/30303306
http://dx.doi.org/10.1111/jdv.15214
_version_ 1783368936569438208
author Hönigsmann, H.
author_facet Hönigsmann, H.
author_sort Hönigsmann, H.
collection PubMed
description Linked article: This is a commentary on Y. Masuda et al., pp. 1456–1460 in the previous issue. To view this article visit https://doi.org/10.1111/jdv.14797
format Online
Article
Text
id pubmed-6221007
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62210072018-11-15 Commentary to “Mogamulizumab‐induced photosensitivity in patients with mycosis fungoides and other T‐cell neoplasms” by Y. Masuda et al. Hönigsmann, H. J Eur Acad Dermatol Venereol Commentaries Linked article: This is a commentary on Y. Masuda et al., pp. 1456–1460 in the previous issue. To view this article visit https://doi.org/10.1111/jdv.14797 John Wiley and Sons Inc. 2018-10-10 2018-10 /pmc/articles/PMC6221007/ /pubmed/30303306 http://dx.doi.org/10.1111/jdv.15214 Text en © 2018 The Author. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Commentaries
Hönigsmann, H.
Commentary to “Mogamulizumab‐induced photosensitivity in patients with mycosis fungoides and other T‐cell neoplasms” by Y. Masuda et al.
title Commentary to “Mogamulizumab‐induced photosensitivity in patients with mycosis fungoides and other T‐cell neoplasms” by Y. Masuda et al.
title_full Commentary to “Mogamulizumab‐induced photosensitivity in patients with mycosis fungoides and other T‐cell neoplasms” by Y. Masuda et al.
title_fullStr Commentary to “Mogamulizumab‐induced photosensitivity in patients with mycosis fungoides and other T‐cell neoplasms” by Y. Masuda et al.
title_full_unstemmed Commentary to “Mogamulizumab‐induced photosensitivity in patients with mycosis fungoides and other T‐cell neoplasms” by Y. Masuda et al.
title_short Commentary to “Mogamulizumab‐induced photosensitivity in patients with mycosis fungoides and other T‐cell neoplasms” by Y. Masuda et al.
title_sort commentary to “mogamulizumab‐induced photosensitivity in patients with mycosis fungoides and other t‐cell neoplasms” by y. masuda et al.
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221007/
https://www.ncbi.nlm.nih.gov/pubmed/30303306
http://dx.doi.org/10.1111/jdv.15214
work_keys_str_mv AT honigsmannh commentarytomogamulizumabinducedphotosensitivityinpatientswithmycosisfungoidesandothertcellneoplasmsbyymasudaetal

Ejemplares similares